← All trials
NCT04778813
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2021
- Primary completion
- Dec 31, 2021
- Completion date
- Jun 1, 2022
- First posted
- Mar 3, 2021
- Last posted
- Mar 3, 2021
- Enrollment
- 1050
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Centre national de recherche et de formation sur le paludismeLead sponsor
- United States Agency for International DevelopmentCollaborator
- Unité de recherche clinique de Nanoro (URCN)Collaborator
- Government of Burkina FasoCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.